Menogaril

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMenogaril
Drug Alias NameTomosarU-520477-OMENTUT-7NSC-269148 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsCarcinoma, Non-Small-Cell LungOvarian Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG